Intrinsiqs

Is Lantern Pharma Inc. overvalued?

Lantern Pharma Inc. (LTRN) — key valuation metrics and fundamentals.

No verdict
Price
$4.02
Fair value
Current P/E
Normal P/E
Market cap
$51.3M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares LTRN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 1 Jul 2026.